Brief Summary
Type:
Lymphomas
Study Type:
Treatment
Phase:
II
ClinicalTrials.gov Identifier:
NCT04947319
Study #:
STUDY00148970
Start Date:
Dec 15, 2022
Full Details and Eligibility at clinicaltrials.gov
By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.
ClinicalTrials.gov ID: NCT04947319
View Complete Trial Details & Eligibility at ClinicalTrials.gov
